|
Category A n/a
|
|
|
|
Category B—Benign symptomatic disease; acute pulmonary disease
|
|
|
|
# of cases=27,936
|
|
|
|
100% of cases typically receive 2 phys. visits at $30/visit
|
= $
|
1,676,000
|
|
100% of cases typically receive diagnostic procedure at $120
|
= $
|
3,352,000
|
|
[skin test, serology, immunodiffusion, chest x-ray, blood count]
|
|
|
|
|
TOTAL (B)
|
= $
|
5,028,000
|
|
Category C—Acute pulmonary disease
|
|
|
|
# of cases=4,414
|
|
|
|
100% of cases typically receive 12 days normal hospitalization at $400/day
|
= $
|
21,187,000
|
|
100% of cases typically receive additional diagnostic testing and treatment at rate equivalent to daily inclusive hospital rate, 12 days at $400/day
|
= $
|
21,187,000
|
|
100% of cases typically receive treatment with one vial amphotericin B/day for 21 days (at $13/vial)
|
= $
|
1,205,000
|
|
# of cases of meningitis=75*
|
|
|
|
100% of cases typically receive 14 days normal hospitalization at $400/day
|
= $
|
420,000
|
|
100% of cases typically receive additional diagnostic testing and treatment at rate equivalent to daily inclusive hospital rate, 14 days at $400/day
|
= $
|
420,000
|
|
100% of cases typically receive treatment of 2 vials amphotericin B/day for 21 days ($13/vial)
|
= $
|
41,000
|
|
|
TOTAL (C)
|
= $
|
44,460,000
|
|
Categories E–G n/a
|
|
|
|
|
TOTAL COST
|
= $
|
49,488,000
|